Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Engineering Research Center for Human Stem Cells (NERC-HSC) is a prominent Chinese biotechnology institution and commercial entity specializing in the research, development, and clinical translation of stem cell technologies. Based in Changsha and affiliated with Central South University and the CITIC Group, the center operates one of the world's largest human embryonic stem cell banks. Its core business encompasses stem cell storage, reproductive health services, and the development of regenerative therapies for complex conditions such as Parkinson's disease and graft-versus-host disease. NERC-HSC integrates basic scientific research with industrial-scale manufacturing, maintaining state-of-the-art GMP facilities for cell product development. The center is a key player in China's national strategy for regenerative medicine and cell-based drug discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Engineering Research Center for Human Stem Cells.